Classic or vector: is the hype around the CoviVac vaccine justified?

Classic or vector: is the hype around the CoviVac vaccine justified?
Photo is illustrative in nature. From open sources.
Experts attribute the rush demand for KoviVac to the reputation of the manufacturer and the classic type of vaccine. There are arguments in favor of vector vaccines,

In recent days, there has been a rush demand in Moscow for the KoviVak CORONAVIRUS vaccine, developed by the Center. Chumakov. On the morning of July 10, the authorities reported that the drug was delivered to 14 pavilions - about 850 doses at each point. Muscovites lined up in huge queues, and by the end of the day, KoviVak was already over. This is not the first time that KoviVac has run out and vaccination centers have been forced to suspend the vaccination campaign with this particular drug.

Sputnik, KoviVak and EpiVakKorona - what's the difference

In RUSSIA, four vaccines against coronavirus infection have been approved so far - in addition to KoviVak, this is Sputnik V of the Center. Gamaleya, its one-component version "Sputnik Light" and "EpiVakKorona" of the Vector center.

KoviVac belongs to the classic type of vaccines - it is a whole-virion inactivated vaccine, it is produced on the basis of a whole "killed" (inactivated) SARS-CoV-2 coronavirus.

The vaccine "KoviVak" arrived in the regions. How is it different from other Society